Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea
· Delayed Price · Currency is KRW
12,910
-420 (-3.15%)
Apr 2, 2025, 3:30 PM KST
Osang Healthcare Co.,Ltd Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Apr '25 Apr 1, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 177,017 | 156,175 | - | - | - | - | |
Enterprise Value | 167,816 | 129,560 | - | - | - | - | |
Last Close Price | 12910.00 | 11390.00 | - | - | - | - | |
PS Ratio | 2.18 | 1.94 | - | - | - | - | |
PB Ratio | 0.62 | 0.55 | - | - | - | - | |
P/TBV Ratio | 0.56 | 0.56 | - | - | - | - | |
EV/Sales Ratio | 2.08 | 1.61 | - | - | - | - | |
EV/FCF Ratio | -2.52 | - | - | - | - | - | |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
Debt / EBITDA Ratio | - | - | 0.00 | 0.01 | - | 0.01 | |
Debt / FCF Ratio | - | - | 0.01 | 0.02 | 0.34 | 0.02 | |
Asset Turnover | 0.26 | 0.26 | 1.25 | 0.88 | 0.61 | - | |
Inventory Turnover | 2.87 | 2.87 | 4.65 | 2.95 | 2.72 | - | |
Quick Ratio | 4.41 | 4.41 | 6.27 | 2.19 | 7.14 | 2.55 | |
Current Ratio | 7.49 | 7.49 | 6.90 | 3.22 | 10.82 | 3.99 | |
Return on Equity (ROE) | -3.93% | -3.93% | 47.31% | 21.49% | 0.78% | - | |
Return on Assets (ROA) | -4.99% | -4.99% | 31.23% | 14.04% | -2.05% | - | |
Return on Capital (ROIC) | -5.29% | -5.29% | 35.97% | 16.22% | -2.34% | - | |
Return on Capital Employed (ROCE) | - | - | 48.50% | 24.60% | - | 81.10% | |
Earnings Yield | -6.42% | -7.28% | - | - | - | - | |
FCF Yield | -37.61% | -42.63% | - | - | - | - | |
Dividend Yield | 3.66% | - | - | - | - | - | |
Payout Ratio | 0.00% | - | 21.77% | 61.25% | 1679.92% | - | |
Buyback Yield / Dilution | -4.03% | -4.03% | -1.68% | -4.37% | 7.21% | -67.60% | |
Total Shareholder Return | -0.37% | -4.03% | -1.68% | -4.37% | 7.21% | -67.60% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.